Utama › Kanser Payudara › Ohio › Cincinnati
Kajian klinikal Kanser Payudara di Cincinnati, OH
25 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Cincinnati (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- dan 3 lagi
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Mengambil pesertaFasa 3
- TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0020), Cincinnati
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Mengambil pesertaFasa 3
- Good Samaritan Hospital-TriHealth Cancer institute ( Site 0027), Cincinnati
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Mengambil pesertaFasa 3
- Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053), Edgewood · 8 mi jauh
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Mengambil pesertaFasa 3
- University of Cincinnati Medical Center, Cincinnati
- University of Cincinnati Medical Center - West Chester Hospital, West Chester · 15 mi jauh
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Mengambil pesertaFasa 3
- Research Site, Cincinnati
- Research Site, Cincinnati
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Mengambil pesertaFasa 3
- Clinical Trial Site, Cincinnati
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mi jauh
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Mengambil pesertaFasa 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi jauh
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Mengambil pesertaFasa 3
- Research Site, Edgewood · 8 mi jauh
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- University of Cincinnati Medical Center, Cincinnati
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Mengambil pesertaKajian pemerhatian
- University of Cincinnati Medical Center, Cincinnati
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- The Christ Hospital, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- dan 2 lagi
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- St. Elizabeth Healthcare, Edgewood · 8 mi jauh
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Mengambil pesertaFasa 3
- Oncology Hematology Care, Cincinnati
E-Mindfulness Approaches for Living After Breast Cancer
Mengambil pesertaFasa 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi jauh
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
Mengambil peserta
- University of Cincinnati, Cincinnati
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Mengambil pesertaFasa 2
- The Christ Hospital Cancer Center, Cincinnati
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Mengambil pesertaFasa 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi jauh
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Mengambil pesertaKajian pemerhatian
- St. Elizabeth Edgewood Hospital, Edgewood · 8 mi jauh
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
Mengambil pesertaFasa 4
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Cincinnati
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Mengambil pesertaFasa 3
- The Christ Hospital, Cincinnati
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi jauh
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Mengambil pesertaKajian pemerhatian
- TriHealth Cancer Institutes, Cincinnati
- Oncology Hematology Care, Cincinnati
Kajian Kanser Payudara di bandar lain
- New York City, NY134 kajian
- Houston, TX126 kajian
- Boston, MA111 kajian
- Nashville, TN80 kajian
- Los Angeles, CA72 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Durham, NC63 kajian
- Queens, NY63 kajian
- Chicago, IL58 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di Cincinnati
- Kanser Paru-paru Bukan Sel Kecil35 kajian
- Kanser (semua jenis)27 kajian
- Kegagalan Jantung24 kajian
- Kanser Kolorektal21 kajian
- Leukemia Mieloid Akut20 kajian
- Kanser Metastatik20 kajian
- Kanser Ovari19 kajian
- Kanser Paru-paru19 kajian
- Obesiti19 kajian
- Kanser Prostat18 kajian
- Mieloma Pelbagai17 kajian
- Melanoma17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.